Humasis, Top Search Ranking... Stock Price -7.22%
Humasis is trading at 12,200 KRW as of 2:30 PM on the 15th, down 7.22% from the previous day. This represents a 125.93% increase compared to June 17. Humasis is known as an in vitro diagnostic device company.
Over the past five days, individual investors have net purchased 112,291 shares, while foreigners and institutions have net sold 66,408 shares and net purchased 181 shares, respectively.
On July 14, Humasis was a market topic due to its "upward trend amid the impact of the COVID-19 resurgence."
※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
While Samsung Falters, China Rises: "Chinese DRAM" Turns a Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Samsung Labor and Management Clash Over Court Injunction Interpretation: "Strike Rights Guaranteed" vs "Clear Misrepresentation" (Comprehensive)
- Despite Captivating the Nation for Over a Month... "Timmy" the Whale Ultimately Found Dead
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
